Daily Trading Analysis 16.12.2020

Technical & Fundamental analysis

Trading Analysis of USD/CAD The Bank of Canada announced its verdict on monetary policy. As widely expected, the Central Bank did not change the level of the key interest rate, leaving it at 0.25%. The text of the accompanying central bank statement noted: The Bank continues to pursue an aggressive communication policy backed and augmented by a QE program that will continue to be implemented at the current rate of C$4 billion per week; The global and Canadian economic recoveries are mostly in line with the Central Bank's October expectations; Economic momentum in Q4 seems stronger than projected in October; Rates will not rise until at least 2023. Our Analysis: Provided that the currency pair is traded above 1.2730, follow the recommendations below: Time frame: 30 min Recommendation: long position Entry point: 1.2730 Take Profit 1: 1.2750 Take Profit 2: 1.2770 Alternative scenario: In case of breakdown of the level 1.2730, follow the recommendations below: Time frame: 30 min Recommendation: short position Entry point: 1.2815 Take Profit 1: 1.2675 Take Profit 2: 1.2650 Learn More Trading Analysis of GOLD/USD Gold rose on Tuesday on market hopes for additional economic support amid the rapid spread of COVID-19 and ahead of the U.S. Federal Reserve's meeting. Our Analysis: Provided that the price is above 1843.00, follow these recommendations: Time frame: 30 min Recommendation: long position Entry point: 1857.00 Take Profit 1: 1866.00 Take Profit 2: 1875.00   Alternative scenario: In case of breakdown of the level 1843.00, follow the recommendations below: Time frame: 30 min Recommendation: short position Entry point: 1843.00 Take Profit 1: 1834.00 Take Profit 2: 1825.00 Learn More Fundamental Trading Analysis of Pfizer  On Friday, the Food and Drug Administration cleared Pfizer's coronavirus vaccine for emergency use. But the news didn't immediately help Pfizer stock. Vaccination began Monday in the U.S. - a week later than in the U.K. Two Pfizer and BioNTech vaccine recipients experienced allergic reactions to the vaccine. Pfizer emphasized that no such side effects were observed among the 44,00 participants in the clinical trial. Our Analysis: Provided that the price is above 36.30, follow these recommendations: Time frame: D1 Recommendation: long position Entry point: 36.50 Take Profit 1: 42.20 Take Profit 2: 43.70  Alternative scenario: In case of breakdown of the level 36.30, follow the recommendations below: Time frame: D1 Recommendation: short position Entry point: 36.30 Take Profit 1: 33.80 Take Profit 2: 32.40 Learn More ‌ ‌ ‌ ‌ ‌ Risk Warning: Forex and CFD trading carry a high degree of risk. As such they may not be suitable for all investors. Investors should ensure they fully understand the risks associated with CFD trading before deciding to trade. Investors may choose to seek independent advice and should not risk more than they are prepared to lose.

Laino Group Limited | Cedar Hill Crest, Villa, Kingstown, St. Vincent & Grenadines Unsubscribe edwardlorilla1986.paxforex@blogger.com About our service provider Sent by info@paxforex.org